Profile data is unavailable for this security.
About the company
RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in HKD (TTM)2.33bn
- Net income in HKD-1.29bn
- Incorporated2008
- Employees3.07k
- LocationRemeGen Co LtdNo.1 Rongchang Road, Yantai ETDZYANTAI 264006ChinaCHN
- Phone+86 5 353573685
- Fax+86 5 356113517
- Websitehttps://www.remegen.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocytogen Phrmutcls (Beijing) Co Ltd | 1.51bn | 282.75m | 34.39bn | 1.28k | 135.18 | 34.62 | 78.28 | 22.83 | 0.5593 | 0.5593 | 2.98 | 2.18 | -- | -- | -- | 1,215,939.00 | -- | -- | -- | -- | 76.56 | -- | 18.77 | -- | 1.11 | 14.77 | 0.5281 | -- | 36.76 | -- | 108.76 | -- | -- | -- |
| Insilico Medicine Cayman TopCo | 418.90m | -346.53m | 43.96bn | -- | -- | -- | -- | 104.94 | -0.6217 | -0.6217 | 0.7515 | -9.55 | -- | -- | -- | -- | -- | -- | -- | -- | 83.56 | -- | -82.72 | -- | -- | -- | -- | -- | 67.71 | -- | 91.92 | -- | -- | -- |
| Shanghai Allist Pharmaceuticals Co Ltd | 5.38bn | 2.24bn | 48.71bn | 1.42k | 21.72 | 6.63 | -- | 9.05 | 4.41 | 4.41 | 10.57 | 14.44 | 0.7497 | 5.75 | 13.98 | 3,357,423.00 | 31.24 | 10.89 | 34.76 | 11.75 | 95.37 | 96.19 | 41.68 | 27.72 | 5.34 | -- | 0.0006 | 24.71 | 76.29 | 462.87 | 121.97 | -- | 24.77 | -- |
| Biocon Ltd | 14.49bn | 520.18m | 53.03bn | 3.44k | 78.42 | -- | 24.55 | 3.66 | 4.85 | 4.85 | 133.23 | -- | -- | -- | -- | 48,888,440.00 | -- | 2.72 | -- | 3.92 | 65.74 | 62.04 | 3.74 | 8.83 | -- | 1.66 | -- | 9.26 | 3.43 | 19.36 | -0.8998 | 5.45 | 4.99 | -- |
| Shanghai Bao Pharmaceuticals Co Ltd | 52.79m | -430.17m | 55.03bn | -- | -- | 54.68 | -- | 1,042.43 | -1.32 | -1.32 | 0.1619 | 3.09 | -- | -- | -- | -- | -- | -- | -- | -- | 97.96 | -- | -814.93 | -- | 2.07 | -- | 0.2168 | -- | -11.11 | -- | -127.21 | -- | -- | -- |
| RemeGen Co Ltd | 2.33bn | -1.29bn | 57.59bn | 3.07k | -- | 17.06 | -- | 24.68 | -2.39 | -2.39 | 4.33 | 4.73 | 0.3555 | 0.4974 | 6.22 | 667,228.60 | -19.60 | -19.20 | -30.76 | -24.02 | 83.34 | 81.26 | -55.15 | -88.39 | 0.8033 | -12.79 | 0.5315 | -- | 58.92 | -- | 2.84 | -- | 32.40 | -- |
| PharmaEssentia Corp | 3.44bn | 1.20bn | 68.58bn | 131.00 | 55.97 | 8.12 | 53.00 | 19.92 | 12.95 | 12.95 | 37.25 | 89.26 | 0.4345 | 1.23 | 4.84 | -- | 15.11 | -5.26 | 16.67 | -5.99 | 89.17 | 82.30 | 34.78 | -19.83 | 6.54 | 64.89 | 0.0291 | -- | 90.67 | 99.81 | 575.37 | -- | 40.94 | -- |
Data as of Feb 16 2026. Currency figures normalised to RemeGen Co Ltd's reporting currency: Hong Kong Dollar HKD
